You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pentostatin

Showing 26 - 50 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia Trial in La Jolla (Low dose vemurafenib plus rituximab)

Recruiting
  • Hairy Cell Leukemia
  • Low dose vemurafenib plus rituximab
  • La Jolla, California
    Scripps MD Anderson Cancer Center
May 19, 2022

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Omaha (drug, genetic, other, procedure, radiation)

Withdrawn
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
Jan 22, 2018

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 31, 2022

Leukemia, Lymphoma Trial in New York (rituximab, cyclophosphamide, pentostatin)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • rituximab
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 13, 2017

Hematologic Malignancies Trial in Italy (UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC))

Unknown status
  • Hematologic Malignancies
  • UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)
  • Bergamo, Italy
  • +7 more
Jan 17, 2019

Leukemia, Lymphoma Trial in Scottsdale, Rochester (bevacizumab, pegfilgrastim, rituximab)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +1 more
May 23, 2017

Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Tumors Trial run by the NCI (75 approved agents, COXEN)

Completed
Has Results
  • Urothelial Carcinoma
  • +2 more
  • 75 approved agents
  • COXEN
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 14, 2020

Renal Cell Carcinoma, GVHD, Engraftment Syndrome Trial run by the NCI (Pentostatin, Sirolimus, Cyclophosphamide)

Completed
Has Results
  • Renal Cell Carcinoma
  • +2 more
  • Pentostatin
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 1, 2017

Chronic Lymphocytic Leukemia, Leukemia Trial (dasatinib and lenalidomide)

Withdrawn
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • dasatinib and lenalidomide
  • (no location specified)
Apr 9, 2019

Leukemia, Lymphoma, Hodgkin's Disease Trial in Tucson (drug, biological, procedure)

Terminated
Has Results
  • Leukemia
  • +5 more
  • Pentostatin
  • +2 more
  • Tucson, Arizona
  • +1 more
Mar 23, 2017

Chronic Graft-versus-host Disease Trial in Germany (PredEver)

Completed
  • Chronic Graft-versus-host Disease
  • Hamburg, Germany
  • +5 more
Apr 1, 2020

Myeloma, Plasma-Cell, Myeloma-Multiple, Myelomatosis Trial in Bethesda, Hackensack (Adoptive Immunotherapy, Rapamycin-Generated

Terminated
Has Results
  • Myeloma, Plasma-Cell
  • +2 more
  • Adoptive Immunotherapy
  • +2 more
  • Bethesda, Maryland
  • +1 more
Dec 3, 2019

B-Chronic Lymphocytic Leukemia Trial in Columbus (Pentostatin, Rituximab, Cyclophosphamide)

Completed
  • B-Chronic Lymphocytic Leukemia
  • Pentostatin
  • +2 more
  • Columbus, Ohio
    Ohio State University
Feb 6, 2017

Hematologic Malignancies Trial in New Haven, Boston, San Antonio (procedure, drug, radiation)

Completed
Has Results
  • Hematologic Malignancies
  • extracorporeal photopheresis
  • +2 more
  • New Haven, Connecticut
  • +2 more
Nov 23, 2016

GVHD, Steroid Refractory GVHD, Acute GVH Disease Trial in Gainesville, Columbus, San Antonio (Infliximab and Basiliximab)

Terminated
Has Results
  • Graft Versus Host Disease
  • +2 more
  • Infliximab and Basiliximab
  • Gainesville, Florida
  • +2 more
Apr 3, 2019

GVHD Trial in Worldwide (Begelomab, Conventional Second-line Treatment)

Terminated
Has Results
  • Graft vs Host Disease
  • Begelomab
  • Conventional Second-line Treatment
  • Duarte, California
  • +26 more
Jan 20, 2020

Chronic Lymphocytic Leukemia Trial in Italy (Pentostatin, Cyclophosphamide, Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Pentostatin
  • +2 more
  • Monza, MB, Italy
  • +11 more
Dec 27, 2016

B-Cell Chronic Lymphocytic Leukemia Trial in United States (Fludarabine, Cyclophosphamide, Rituximab)

Completed
Has Results
  • B-Cell Chronic Lymphocytic Leukemia
  • Ocoee, Florida
  • +10 more
Sep 15, 2016

GVHD Trial in Columbus (Pentostatin)

Completed
  • Graft-Versus-Host Disease
  • Pentostatin
  • Columbus, Ohio
    Ohio State University
Apr 25, 2016

Lymphoma Trial in Houston (Cytoxan, Nipent, Rituxan)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 13, 2016

Leukemia, Lymphoma Trial in New York (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • filgrastim
  • +12 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 7, 2016

Leukemia, Lymphoma, Multiple Myeloma Trial in Boston (Umbilical Cord Blood After Myeloablative Conditioning, Umbilical Cord

Terminated
Has Results
  • Leukemia
  • +3 more
  • Umbilical Cord Blood After Myeloablative Conditioning
  • Umbilical Cord Blood After Reduced-Intensity Conditioning
  • Boston, Massachusetts
    Tufts Medical Center
May 1, 2017

Leukemia, Lymphoma Trial in Houston (Pentostatin, Tacrolimus, Methotrexate)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Pentostatin
  • +2 more
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Apr 6, 2015

Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation Trial in Houston, Seattle (Neihulizumab

Withdrawn
  • Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
  • Neihulizumab Treatment
  • Conventional Treatment
  • Houston, Texas
  • +1 more
Apr 22, 2016

Rituximab in Hairy Cell Leukemia:Multicenter Retrospective Study

Completed
  • Hairy-cell Leukemia
  • Data collection
  • Reims, France
    Chu de Reims
Aug 25, 2016